Zio AT ECG Monitoring System vs KardiaPro
AI Verdict
Choose Zio AT ECG Monitoring System if…
Choose Zio AT if you require extended, continuous, and uninterrupted ECG monitoring for up to 14 days to detect elusive or infrequent arrhythmias. This system is ideal for patients with suspected paroxysmal atrial fibrillation or other transient symptoms where shorter monitoring periods might miss critical events, offering comprehensive AI-powered analysis and detailed end-of-wear reports for clinicians.
View Zio AT ECG Monitoring System →Choose KardiaPro if…
Choose KardiaPro if you need a comprehensive, web-based platform for remote monitoring of various cardiac data points, including ECG, blood pressure, and weight, particularly for patients using personal KardiaMobile devices. This tool is best suited for managing and reviewing longitudinal patient data between appointments, enabling efficient trend analysis and informed clinical decision-making for a broader range of cardiac conditions.
View KardiaPro →For physicians evaluating AI-powered cardiac monitoring solutions, the Zio AT ECG Monitoring System and KardiaPro offer distinct approaches to remote patient management. Zio AT excels in continuous, long-term ECG monitoring for arrhythmia detection. Its wearable patch provides uninterrupted recording for up to 14 days, transmitting data in real-time via a wireless gateway. This makes it particularly well-suited for identifying intermittent or asymptomatic cardiac events that might be missed with shorter monitoring periods. The system’s FDA-cleared deep-learned AI algorithm (ZEUS System) processes this continuous data to generate comprehensive end-of-wear reports, streamlining the diagnostic process for clinicians.
In contrast, KardiaPro offers a broader, more integrated remote monitoring platform. While it also features FDA-cleared AI for arrhythmia detection, its key practical difference lies in its ability to manage and review not only ECG data (from KardiaMobile devices) but also blood pressure and weight data. This comprehensive web-based portal allows for trend visualization and automated summary reports, providing a more holistic view of a patient’s cardiac health between appointments. Physicians primarily focused on extended, uninterrupted ECG rhythm analysis for elusive arrhythmias would likely favor Zio AT. However, those seeking a unified platform to manage multiple vital signs and track broader cardiac health trends for a diverse patient population may find KardiaPro to be the more suitable choice.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Zio AT ECG Monitoring System | KardiaPro |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based (data analytics and clinician portal) | Cloud-hosted, Web-based |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Zio AT ECG Monitoring SystemTool A (Zio AT) appears to have a slight edge in usability due to its 'wear and forget' patch design, which is water-resistant and has no external wires, leading to high patient compliance. While Tool B (KardiaPro) offers a user-friendly app and portal, the Zio AT's physical design seems to minimize patient burden for continuous, long-term monitoring.
Clinical Value
Zio AT ECG Monitoring SystemTool A (Zio AT) offers continuous, uninterrupted ECG recording for up to 14 days, which has been shown to result in higher cardiac arrhythmia detection rates compared to shorter monitoring periods. Its FDA-cleared deep-learned AI algorithm and comprehensive end-of-wear reports, reviewed by certified cardiographic technicians, provide a high diagnostic yield and physician agreement. Tool B (KardiaPro) also uses FDA-cleared AI for arrhythmia detection and integrates with various devices, but its primary focus appears to be on remote monitoring of patient-initiated ECGs and other vital signs, rather than continuous, long-term diagnostic recording.
Pricing & Value
TieBoth Tool A (Zio AT) and Tool B (KardiaPro) require contacting the company for pricing, indicating a lack of public transparency. Both services are reimbursable using existing CPT codes, and both companies offer patient assistance or support for navigating insurance. Without specific pricing details, it's difficult to determine which offers better value.
Enterprise Readiness
KardiaProTool B (KardiaPro) demonstrates stronger enterprise readiness through its comprehensive web-based portal for managing various patient data (ECG, BP, weight), customizable ECG inbox for efficient review, automated summary reports, and seamless integration with KardiaStation for point-of-care solutions. It also explicitly mentions supporting EHR/third-party interoperability with SDK/API configurations. While Tool A (Zio AT) offers a clinician portal and mobile app, its enterprise features appear more focused on its specific monitoring service rather than a broader patient data management platform.
Innovation
Zio AT ECG Monitoring SystemTool A (Zio AT) stands out with its 'wear and forget' patch design for continuous, uninterrupted ECG recording for up to 14 days, which is a significant advancement over traditional Holter monitors. Its FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection and comprehensive end-of-wear reports represent a highly integrated and advanced diagnostic approach. While Tool B (KardiaPro) utilizes FDA-cleared AI and integrates with personal ECG devices, the Zio AT's extended continuous monitoring and integrated service model offer a more innovative approach to long-term arrhythmia detection.
Support & Docs
TieBoth companies provide resources for healthcare professionals and patients. iRhythm (Tool A) offers a redesigned MyZio app with educational content and a help center, along with patient advocates for insurance questions. AliveCor (Tool B) also has a web-based portal and offers support for its devices. Without more specific details on the breadth, depth, and accessibility of their documentation and support channels, it is difficult to definitively pick a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Zio AT ECG Monitoring System | KardiaPro |
|---|---|---|
| Tool Name | Zio AT ECG Monitoring System | KardiaPro |
| Company | iRhythm Technologies, Inc. | AliveCor |
| Description | The Zio AT ECG Monitoring System by iRhythm Technologies is an FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. | KardiaPro is a comprehensive web-based portal for remote monitoring of patient ECG, blood pressure, and weight data, with FDA-cleared AI for arrhythmia detection and other cardiac determinations. It provides a secure platform to manage and review data between appointments, making it easy for healthcare professionals to analyze trends and make informed clinical decisions for improved patient care. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Clinical Decision Support & Reference, Wearables & Remote Monitoring (RPM) |
| Specialties | Cardiology | Cardiology, Family Medicine, Internal Medicine |
| Key Features (Monitoring Data) | Continuous, uninterrupted ECG recording for up to 14 days | ECG, blood pressure, and weight data management |
Videos
Demos, reviews, and walkthroughs featuring Zio AT ECG Monitoring System and KardiaPro.
Frequently Asked Questions
More Comparisons
More matchups featuring Zio AT ECG Monitoring System or KardiaPro
Backers
Who funded each tool's parent company.